Chapin Davis, Inc. Bristol Myers Squibb CO Transaction History
Chapin Davis, Inc.
- $362 Billion
- Q2 2025
A detailed history of Chapin Davis, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chapin Davis, Inc. holds 28,438 shares of BMY stock, worth $1.38 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
28,438
Previous 29,714
4.29%
Holding current value
$1.38 Million
Previous $1.81 Billion
27.36%
% of portfolio
0.36%
Previous 0.62%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,738Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.27 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.23 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.59 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.22 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...